Zobrazeno 1 - 10
of 495
pro vyhledávání: '"Henry Mark Kuerer"'
Publikováno v:
Journal of Breast Imaging. 3:659-665
Knowledge of axillary nodal status is highly important for correct staging and treatment planning in patients with breast cancer. Axillary US is a recognized highly specific and cost-effective tool for assessing nodal status and guiding appropriate t
Autor:
Deanna L. Lane, Kelly K. Hunt, Marion E. Scoggins, Aysegul A. Sahin, Yu Shen, Wei T. Yang, Elizabeth A. Mittendorf, Henry Mark Kuerer, Savitri Krishnamurthy, Alastair M. Thompson, Heather Lin, Isabelle Bedrosian, Janine M. Simons, Abigail S. Caudle
Publikováno v:
Annals of Surgical Oncology, 28(8), 4277-4283. Springer, Cham
Background Targeted axillary dissection (TAD) involves locating and removing both clipped nodes and sentinel nodes for assessment of the axillary response to neoadjuvant chemotherapy (NAC) by clinically node-positive breast cancer patients. Initial r
Autor:
Lyndsey J. Kilgore, Henry Mark Kuerer, Lauren M. Postlewait, Brittany L. Murphy, Mediget Teshome, Isabelle Bedrosian, Anthony Lucci, Kelly K. Hunt, Diana H. Liang
Publikováno v:
Journal of Surgical Oncology
Introduction The early COVID‐19 pandemic rapidly transformed healthcare and medical education. We sought to evaluate the professional and personal impact of the pandemic on 2019–2020 Breast Surgical Oncology (BSO) fellows in Society of Surgical O
Autor:
Funda Meric-Bernstam, Leisha C. Elmore, Henry Mark Kuerer, Makesha V. Miggins, Kelly K. Hunt, Abigail S. Caudle, Carlos H. Barcenas, Mediget Teshome, Benjamin Smith, Anthony Lucci
Publikováno v:
Annals of Surgical Oncology. 28:5477-5485
Neoadjuvant systemic therapy (NST) is standard for locally advanced breast cancer and is now frequently considered for those with early-stage and node-positive disease. We aimed to evaluate the treatment course and outcomes in patients with disease p
Autor:
Mediget Teshome, Lauren M. Postlewait, Huong T. Le-Petross, Bora Lim, Isabelle Bedrosian, Vicente Valero, Wendy A. Woodward, Susie X. Sun, Taiwo Adesoye, Henry Mark Kuerer, Anthony Lucci, Naoto T. Ueno, Sarah M. DeSnyder
Publikováno v:
Annals of Surgical Oncology. 28:8610-8621
Nearly one-third of patients with inflammatory breast cancer (IBC) present with de novo stage IV disease. There are limited data on frequency and clinical outcomes of contralateral axillary metastasis (CAM) in IBC with no consensus diagnostic and tre
Autor:
John R. Benson, Ivan Moschetti, Rachel O'Connell, Carmen Criscitiello, Michela Cinquini, Zoe Winters, Loredana Pau, Giacomo Montagna, Giuseppe Catanuto, Nicola Rocco, Henry Mark Kuerer, Nahid Nafissi, Achilles Thoma, Serena Oliveri, Rosa Di Micco, Werner Audretsch, Tibor Kovacs, Gianfranco Scaperrotta, Maurizio B. Nava, Laura Lozza
Publikováno v:
Breast, Vol 57, Iss, Pp 25-35 (2021)
The Breast : Official Journal of the European Society of Mastology
The Breast : Official Journal of the European Society of Mastology
Introduction The potential advantages of oncoplastic breast conserving surgery (BCS) have not been validated in robust studies that constitute high levels of evidence, despite oncoplastic techniques being widely adopted around the globe. There is hen
Autor:
Ryan Suk, Scott B. Cantor, Susie X. Sun, Ashish A. Deshmukh, Benjamin M. Raber, Henry Mark Kuerer
Publikováno v:
Annals of Surgical Oncology. 29:39-41
Autor:
Wonshik Han, Marios Konstantinos Tasoulis, Benjamin Smith, Joerg Heil, Geraldine Rauch, Chris Sidey-Gibbons, Walter P. Weber, Michael Golatta, Vivian Koelbel, André Pfob, Vicente Valero, Fiona MacNeill, Gaiane M. Rauch, Han-Byoel Lee, Henry Mark Kuerer
Publikováno v:
Cancer Research. 81:PS2-42
Purpose: Neoadjuvant systemic treatment elicits a pathologic complete response (pCR) in an average of 35% of women with breast cancer. In such cases, breast surgery may be considered overtreatment. However, imaging and vacuum-assisted biopsy (VAB) al
Autor:
Kelly K. Hunt, Mariana Chavez-Mac Gregor, Sarah M. DeSnyder, Benjamin Smith, Henry Mark Kuerer, Abigail S. Caudle, Min Yi
Publikováno v:
Cancer Research. 81:PS1-17
Background: Over the last decade, patients with early-stage breast cancer have been undergoing total mastectomy (TM) with increasing frequency. Our center reported that local recurrence rates with breast conserving therapy (BCT) declined throughout t
Autor:
Salyna Meas, Anthony Lucci, Henry Mark Kuerer, Juhee Song, Vicente Valero, Sarah M. DeSnyder, Carolyn S. Hall, Kelly Rosso, Mediget Teshome, Lauren M. Postlewait, Wendy A. Woodward, Bora Lim, Naoto T. Ueno, Natalia S. Partain
Publikováno v:
Annals of Surgical Oncology. 28:4265-4274
The role of modified radical mastectomy (MRM) in patients with de novo stage IV inflammatory breast cancer (IBC) remains controversial. We evaluated the impact of MRM on outcomes in this population. Ninety-seven women presenting with stage IV IBC wer